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Five novel silver(I) complexes with 4,7-phenanthroline (4,7-phen), [Ag(NO3-O)(4,7-phen-
µ-N4,N7)]n (1), [Ag(ClO4-О)(4,7-phen-µ-N4,N7)]n (2), [Ag(CF3COO-O)(4,7-phen-µ-
N4,N7)]n (3), [Ag2(H2O)0.58(4,7-phen)3](SbF6)2 (4) and {[Ag2(H2O)(4,7-phen-µ-
N4,N7)2](BF4)2}n (5) were synthesized, structurally elucidated and biologically evaluated. 
These complexes showed selectivity towards Candida spp. in comparison to the tested 
bacteria and effectively inhibited the growth of four different Candida species, particularly 
of C. albicans strains, with minimal inhibitory concentrations (MICs) in the range of 2.0 – 
10.0 µM. In order to evaluate the therapeutic potential of 1 – 5, in vivo toxicity studies 
were conducted in the zebrafish model. Based on the favorable therapeutic profiles, 
complexes 1, 3 and 5 were selected for the evaluation of their antifungal efficacy in vivo 
using the zebrafish model of lethal disseminated candidiasis. Complexes 1 and 3 efficiently 
controlled and prevented fungal filamentation even at sub-MIC doses, while drastically 
increased the survival of the infected embryos. Moreover, at the MIC doses, both 
complexes totally prevented C. albicans filamentation and rescued almost all infected fish 
of the fatal infection outcome. On the other side, complex 5, which demonstrated the 
highest antifungal activity in vitro, affected the neutrophils occurrence of the infected host, 
failed to inhibit the C. albicans cells filamentation and showed a poor potential to cure 
candidal infection, highlighting the importance of the in vivo activity evaluation early in 
the therapeutic design and development process. The mechanism of action of the 
investigated silver(I) complexes was related to the induction of reactive oxygen species 
(ROS) response in C. albicans, with DNA being one of the possible target biomolecules. 
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Fig. S2. Complex 4 stability over time measured by 1H NMR spectroscopy. 1H NMR 


















Fig. S3. Complex 4 stability over time followed by UV-Vis spectrophotometry in 






































































Fig. S5. (A) Absorption spectra of the silver(I) complexes 1 – 5 in Tris buffer upon 
addition of DNA. Arrow shows the change of absorbance upon increasing concentration of 







































Fig. S6. (A) Fluorescence emission spectra of EthBr bound to DNA in the absence and 
presence of the silver(I) complexes in Tris buffer at 25 oC. Arrow shows the change upon 
increasing concentration of complex. (B) Stern-Volmer plots of relative EthBr-DNA 





































Fig. S8. CV voltammograms of DNA after addition of complex 4 in the concentrations 















Fig. S9. Toxicity evaluation of silver(I) complexes 1, 3 and 5 in the zebrafish model. The 
normally developed fish are shown on the left panel of photos including the control one 
(DMSO-treated), while the affected (teratogenic) fish are shown on the right panel. In 
comparison to the untreated fish, the teratogenic fish upon complexes showed signs of 
weak hepatotoxicity – slightly darker liver (boxed area), weakly absorbed the yolk 







Fig. S10. Eradication of C. albicans infection from the body of zebrafish larvae after the 3 
days treatments with different doses (½×MIC, 1×MIC and 2×MIC) of silver(I) complexes 
1, 3 and 5. In the untreated embryos at 3 dpi (120 hpf), fungal infection has mainly been 
localized in the head (arrow) and the intestine (dashed arrow). Complexes 1 and 3 
successfully inhibited fungal filamentation by 4 dpi at any applied dose, while the 






Table S1  
Details of the crystal structure determinations of the silver(I) complexes 1 – 5. 
 1 2 3 4 5 
Empirical formula C12H8AgN3O3 C12H8AgClN2O4 C14H8AgF3N2O2 C36H25.15Ag2F12N6O0.58Sb2 C24H18Ag2B2F8N4O 
CCDC number 1879001 1879002 1879003 1879004 1880758 
Formula weight (g/mol) 350.08 387.52 401.09 1238.21 767.78 
Crystal system, space group monoclinic, P21/c monoclinic, P21/c monoclinic, P21/c triclinic, Pī triclinic, Pī 
a (Å) 10.7794(15) 10.2659(6)  11.7244(14) 10.7878(8)  7.1974(4) 
b (Å) 14.485(2) 14.6602(11)  14.7916(16) 12.1188(8)  11.8682(6) 
c (Å) 7.320(2) 7.9925(7)  7.4544(9) 14.5250(10)  15.0708(8) 
 (°)    82.918(5)  79.146(4) 
  (°) 100.585(17) 97.922(6) 95.644(10) 88.316(6)  76.397(4) 
  (°)    85.176(6)  82.976(4) 
V (Å3) 1123.5(4) 1191.39(15) 1286.5(3) 1877.4(2) 1224.75(12) 
F000 688 760 784 1184 748 
 4 4 4 2 2 
X-radiation,   /Å Mo-Kα 0.71073 Mo-Kα 0.71073 Mo-Kα 0.71073 Mo-Kα 0.71073 Mo-Kα 0.71073 
data collect. temperat.  /K 298(2) 250(2) 298(2) 250(2) 200(2) 
Calculated density (Mg/m3) 2.070 2.160 2.071 2.190 2.082 
Absorption coefficient (mm-1) 1.801 1.931 1.612 2.551 1.689 
Crystal size (mm3) 0.64 × 0.26 × 0.02 0.38 x 0.167 x 0.04 0.39 × 0.17 × 0.05 0.37 × 0.183 × 0.07 0.30 × 0.15 × 0.06 
 range (°) 3.8 to 50.5 4.0 to 50.5 3.4 to 50.6 2.8 to 50.5 3.5 to 50.2 
index ranges h, k, l -12 ... 12, -17 ... 17, -8 ... 8 -12 … 12, -17… 17, -9 ... 9 -14 ... 13, -17 ... 17, -8 ... 8 -12 ... 12, -14 ... 14, -17 ... 17 -8 ... 8, -14 ... 14, -17 ... 17 
No. of collected and independent 
reflections 
12782, 2013 12271, 2126 16077, 2296 6286, 6286 13046, 4351 
Rint 0.0684 0.0371 0.1070  0.0391 
Data / restraints / parameters 2013 / 0 / 172 2126 / 0 / 181 2296 / 0 /199 6286 / 57 / 408 4351 / 3 / 376 
Goodness-on-fit on F2 1.040 1.034 1.055 1.041 1.045 
Final R indices 
 [I ≥ 2(I)] 
0.0362, 0.0727 0.0232, 0.0546 0.0346, 0.0800 0.0929, 0.2586 0.0237, 0.0628 
Final R indices 
 (all data)  
0.0543, 0.0779 0.0348, 0.0579 0.0497, 0.0888 0.1125, 0.2837 0.0268, 0.0645 






Lethal and teratogenic effects observed in zebrafish (Danio rerio) embryos at different 
hours post fertilization (hpf). 
aNo clear organs structure is recognized. 
bMalformation of eyes was recorded for the retardation in eye development and abnormality in 
shape and size. 
cPresence of none, one or more than two otoliths per sacculus, as well as reduction and enlargement 
of otoliths and/or sacculi (otic vesicles). 
dTail malformation was recorded when the tail was bent, twisted or shorter than to control embryos 
as assessed by optical comparation. 
eGrowth retardation was recorded by comparing with the control embryos in a body length (after 
hatching, at and onwards 72 hpf) using by optical comparation using an inverted microscope 










Category   Developmental endpoints  Exposure time (hpf) 
    48 72 96 120 
        
Lethal effect Coagulated eggs  ● ● ● ● 
  Lack of the heart beating  ● ● ● ● 
Teratogenic effect Malformation of head  ● ● ● ● 
  Malformation of eyes  ● ● ● ● 
  Malformation of sacculi/otoliths  ● ● ● ● 
  Malformation of chorda  ● ● ● ● 
  Malformation of tail  ● ● ● ● 
  Scoliosis  ● ● ● ● 
  Yolk edema  ● ● ● ● 
  Yolk deformation  ● ● ● ● 
  Growth retardation   ● ● ● 
  Hatching    ● ● 
Cardiotoxicity  Pericardial edema   ● ● ● 
  Heart morphology    ● ● 





Table S3  
Selected bond distances (Å) and valence angles (o) in silver(I) complexes 1 – 5. 
1 2 3 4 5 
Ag1—N1 2.274(3) Ag1—N1 2.196(2) Ag1—N1 2.239(3) Ag1—N3 2.111(15) Ag1—N3 2.168(2) 
Ag1—N2 2.268(3) Ag1—N2i 2.193(2) Ag1—N2 2.254(3) Ag1—N2 2.102(13) Ag1—N1 2.170(2) 
Ag1—O3 2.544(4) Ag1—O1 2.571(2) Ag1—O1 2.440(3) Ag2—O1 2.43(2) Ag2—N4 2.161(2) 
Ag1—O1 3.495(5)   Ag1—O2iii 2.635(4) Ag2—N4 2.135(14) Ag2—N2iv 2.171(2) 
Ag1—O2’ 2.739(6)     Ag2—N5 2.155(11) Ag2—O1 2.631(2) 
Ag1—O3’ 2.759(6)         
          
N1—Ag1—N2 139.34(12) N2i—Ag1—N1 150.98(9) N1—Ag1—N2 144.95(12) N2—Ag1—N3 175.4(5) N1—Ag1—N3 165.01(8) 
N1—Ag1—O3 113.16(12) N2i—Ag1—O1 110.70(9) N1—Ag1—O1 124.22(12) N4—Ag2—O1 93.8(6) N2iv—Ag2—N4 162.57(8) 
N2—Ag1—O3 92.34(13) N1—Ag1—O1 86.10(9) N2—Ag1—O1 89.78(12) N4—Ag2—N5 167.7(5) C1—N1—Ag1 119.40(17) 
C1—N1—Ag1 120.9(3) C1—N1—Ag1 120.2(2) N1—Ag1—O2iii 84.49(11) N5—Ag2—O1 98.5(6) C5—N1—Ag1 121.88(16) 
C5—N1—Ag1 121.4(2) C5—N1—Ag1 120.44(18) N2—Ag1—O2iii 107.51(12) C13—N3—Ag1 121.0(10) C12—N2—Ag2v 121.07(19) 
C12—N2—Ag1 119.2(3) C12—N2—Ag1ii 120.3(2) O1—Ag1—O2iii 87.43(13) C17—N3—Ag1 122.1(12) C8—N2—Ag2v 120.30(17) 
C8—N2—Ag1 121.3(3) C8—N2—Ag1ii 121.67(19) C1—N1—Ag1 120.5(3) C12—N2—Ag1 119.2(11) C13—N3—Ag1 118.75(18) 
N3—O3—Ag1 123.2(3) Cl1—O1—Ag1 125.91(14) C5—N1—Ag1 121.1(2) C8—N2—Ag1 124.1(11) C17—N3—Ag1 122.34(16) 
    C12—N2—Ag1 117.6(3) C20—N4—Ag2 124.5(12) C24—N4—Ag2 120.67(18) 
    C8—N2—Ag1 123.2(2) C24—N4—Ag2 119.4(10) C20—N4—Ag2 120.59(16) 
    C25—O1—Ag1 147.4(3) C25—N5—Ag2 118.9(10)   
    C25—O2iii—Ag1 117.1(3) C29—N5—Ag2 123.1(10)   
          
BVSAg1 0.97 BVSAg1 1.32 BVSAg1 1.01 BVSAg1 0.97 BVSAg1 0.84 
      BVSAg2 1.13 BVSAg2 1.39 
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D–H [Å] D···A [Å] H···A [Å] D-H···A [°] Symmetry codes 
4      
O1–H1A···N1 0.87(2) 2.66(3) 1.944(17) 139.4(18) +x, +y, -1+z 
O1–H1B···N1 0.91(2) 3.16(3) 2.360(19) 147.1(19) 
 
1-x, 2-y, 2-z 
5      
O1–H1B···F7 0.832(18) 2.897(3) 2.12(2) 155(3) 2-x, 1-y, 1-z 
O1–H1B···F5 0.832(18) 3.054(3) 2.34(3) 144(3) x+1, y, z-1 
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1 1.03.104 -5.5  (2.62 ± 0.10).103 19.7 2.62.1011 4.23.104 1.30 
2 1.22.103 -4.2  (1.72 ± 0.05).103 13.0 1.72.1011 9.56.103 1.18 
3 7.00.103 -5.2  (2.65 ± 0.05).103 20.8 2.65.1011 2.78.103 1.01 
4 3.74.103 -4.9  (2.06 ± 0.10).103 13.7 2.06.1011 1.12.103 0.92 
5 1.20.104 -5.5  (3.23 ± 0.06).103 24.6 3.23.1011 1.47.103 0.91 
